OC&C advises Foundation Consumer Healthcare on $1.045bn sale of Breathe Right® and consumer health brands to Prestige

OC&C is pleased to have supported Foundation Consumer Healthcare on the sale of a portfolio of consumer health brands, including Breathe Right® nasal strips, to Prestige Consumer Healthcare. Leaders within our Consumer Health growth platform provided strategy support to Foundation before and throughout the transaction.

The portfolio includes a set of well-established over-the-counter healthcare brands, including the leading nasal strip brand Breathe Right®, recognised for its efficacy in improving nasal airflow. The transaction marks a deliberate step in Foundation Consumer Healthcare’s strategy to actively manage its brand portfolio, reallocating capital towards higher-growth opportunities.

Prestige Consumer Healthcare, a leading provider of over-the-counter health and personal care products, is acquiring the portfolio for $1.045 billion, adding a set of well-established, high-recognition brands that deepen its offering across everyday self-care categories.

OC&C brought deep sector expertise in consumer health and a strong track record in supporting portfolio strategy and transaction readiness. Our team worked closely with Foundation Consumer Healthcare to shape the future growth strategy of the business, underpinned by robust market and consumer insights, helping position the portfolio effectively for a successful sale.

OC&C and Private Equity

We’re a leading global strategy consultancy, with deep expertise in Consumer and Consumer Health. We work with both major global corporations and private equity investors. In private equity, we have commercially advised on more than 500 successful transactions over the last 5 years, encompassing sell-side and buy-side roles.

How we can help:

• We provide commercial due diligence and vendor due diligence for transactions.
• We assist investors with accelerating or improving their portfolio companies’ performance.
• We help investors identify potential investment themes or assets to target.
• We can translate your investment thesis into an actionable 3–5 year value creation plan.

For more details on our experience in this space, get in touch with our experts below, or email [email protected].